Pharmaceutical Market Europe • March 2024 • 3
COMMENT
As our cover story for this month’s issue, we’re delighted to feature Rippon Ubhi, Country Lead for UK & Ireland, as she takes up her new role. Having worked in a number of different countries, including the UK, the US and Japan, Rippon has almost two decades of senior commercial leadership experience.
Talking about her different experiences, Rippon says: “Japan was my first international role and I learnt a huge amount both professionally and personally. I was thrown into this completely different way of life. In my first few months, I felt like an outsider. I was the only woman on the leadership team, which I knew was going to be tough. Luckily, I had some amazing people who took me under their wing and showed me the ropes.”
She goes on to say: “My biggest challenge has always been finding my voice in a male-dominated industry. Resisting the temptation to become someone else or fit into a certain mould. In recent years, I’ve had the privilege of learning from both male and female mentors, and their guidance has been instrumental in helping me stay true to myself.” Read more on page 16 about Rippon’s experiences and how they led her to her current role.
Then, turn to page 20 for our article from Matias Ferraris, International Medical Affairs Head at Novartis Neuroscience, where Matias talks about the importance of the patient voice for people with MS and how collaborative, shared decision-making can result in integrating all stakeholders involved in patient care, empowering patients to be advocates and active participants in managing the course of their MS.”
Go to page 24 to read the article on the recent Bioinfect 2024 conference that took place in Liverpool, focusing on the ongoing threat from AMR and the progress being made.
With an eye on the sky in the hopes of some warm spring sunshine and being able to put away our winter coats, I hope you enjoy this issue!
Iona Everson
Group Managing Editor
Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at www.pmlive.com/register
THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Deputy Editor
Emily Kimber
Journalist/Editorial Assistant
Jen Brogan
Studio:
Executive Director
Karl Equi
Sales:
Business Director
Tara Lovegrove
EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals
PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201
CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com
Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2024 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW